WO2020238297A1 - Soft capsule containing nadh or nadph, preparation method therefor and application thereof - Google Patents
Soft capsule containing nadh or nadph, preparation method therefor and application thereof Download PDFInfo
- Publication number
- WO2020238297A1 WO2020238297A1 PCT/CN2020/076287 CN2020076287W WO2020238297A1 WO 2020238297 A1 WO2020238297 A1 WO 2020238297A1 CN 2020076287 W CN2020076287 W CN 2020076287W WO 2020238297 A1 WO2020238297 A1 WO 2020238297A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nadph
- nadh
- soft capsule
- glue
- edible
- Prior art date
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- ACFIXJIJDZMPPO-NCHANQSKSA-N nadph Chemical compound C1=CCC(C(=O)N)=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2[C@@H]([C@H](OP(O)(O)=O)[C@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NCHANQSKSA-N 0.000 title 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims abstract description 109
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims abstract description 87
- 239000008157 edible vegetable oil Substances 0.000 claims abstract description 23
- 229940069428 antacid Drugs 0.000 claims abstract description 13
- 239000003159 antacid agent Substances 0.000 claims abstract description 13
- 230000001458 anti-acid effect Effects 0.000 claims abstract description 12
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 10
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 6
- 230000036541 health Effects 0.000 claims abstract description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000003292 glue Substances 0.000 claims description 55
- 239000000203 mixture Substances 0.000 claims description 55
- 238000003756 stirring Methods 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 239000002775 capsule Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 14
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 14
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 14
- 229920002581 Glucomannan Polymers 0.000 claims description 14
- 229920002752 Konjac Polymers 0.000 claims description 14
- 229940046240 glucomannan Drugs 0.000 claims description 14
- 239000000252 konjac Substances 0.000 claims description 14
- 235000010485 konjac Nutrition 0.000 claims description 14
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 13
- 229940072056 alginate Drugs 0.000 claims description 13
- 235000010443 alginic acid Nutrition 0.000 claims description 13
- 229920000615 alginic acid Polymers 0.000 claims description 13
- 239000002861 polymer material Substances 0.000 claims description 10
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 9
- 235000010413 sodium alginate Nutrition 0.000 claims description 9
- 239000000661 sodium alginate Substances 0.000 claims description 9
- 229940005550 sodium alginate Drugs 0.000 claims description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 238000000227 grinding Methods 0.000 claims description 7
- 238000010112 shell-mould casting Methods 0.000 claims description 7
- -1 fatty acid salt Chemical class 0.000 claims description 6
- 239000012778 molding material Substances 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 240000001548 Camellia japonica Species 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 235000013539 calcium stearate Nutrition 0.000 claims description 4
- 239000008116 calcium stearate Substances 0.000 claims description 4
- 235000018597 common camellia Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 235000021388 linseed oil Nutrition 0.000 claims description 4
- 239000000944 linseed oil Substances 0.000 claims description 4
- 229940057917 medium chain triglycerides Drugs 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 3
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 235000010408 potassium alginate Nutrition 0.000 claims description 3
- 239000000737 potassium alginate Substances 0.000 claims description 3
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229960001855 mannitol Drugs 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 claims description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims 18
- 239000004698 Polyethylene Substances 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 abstract 3
- 239000006187 pill Substances 0.000 description 22
- 230000000694 effects Effects 0.000 description 15
- 230000001681 protective effect Effects 0.000 description 11
- 238000002156 mixing Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000006555 catalytic reaction Methods 0.000 description 5
- 239000000084 colloidal system Substances 0.000 description 5
- 210000004211 gastric acid Anatomy 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 239000008158 vegetable oil Substances 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 239000000576 food coloring agent Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 1
- 108010025076 Holoenzymes Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention belongs to the field of medical technology and health food technology, and particularly relates to a soft capsule containing NADH or NADPH, and a preparation method and application thereof.
- Nicotinamide-Adenine Dinucleotide (NADH) And nicotinamide-adenine-phosphate-dinucleotide (NADPH) It is a physiological substance in the human body and exists in all living cells including human cells. These substances are cofactors of many enzymes, and most of these enzymes can catalyze oxidation-reduction reactions.
- NADH or NADPH participates in thousands of physiological and metabolic reactions in the human body, and plays an important role in gene repair, immunity enhancement, anti-oxidation, and sleep improvement. Adequate NADH or NADPH can make the body better protected and less healthy. Problems, prevention and control of diseases, and supplementation of NADH or NADPH in vitro is beneficial to promote various physiological functions of the body to maintain the best condition.
- NADH or NADPH is a biological form of hydrogen, which is extremely unstable. Light, acidic environment, or oxygen and moisture in the air will destroy the molecular structure of NADH or NADPH.
- NADH or NADPH was mainly used in the form of infusion and tablets, and due to its chemical instability, the infusion needed to be prepared fresh, and it was difficult to ensure its activity during the preparation process.
- the preparation of tablets is simple, the preparation process requires Add more excipients, and the bioavailability is not high.
- the purpose of the present invention is to overcome the above-mentioned shortcomings of the prior art, and firstly provides a soft capsule containing NADH or NADPH.
- the present invention provides a soft capsule containing NADH or NADPH.
- the contents of the soft capsule include NADH or NADPH and edible vegetable oil or/and edible alcohol.
- the quality of the edible vegetable oil or/and edible alcohol is determined Said NADH or NADPH quality 1-2 times.
- the present invention also provides a method for preparing the above-mentioned soft capsules containing NADH or NADPH, which includes the following steps:
- the raw material mixture and the sieved glue are used to prepare soft capsules with a capsule making machine, which is shaped and dried.
- the preparation method of the above-mentioned NADH or NADPH-containing soft capsule provided by the present invention has a simple preparation process and is easy to realize, and further improves the bioavailability and administration effect of NADH or NADPH.
- the present invention also provides the application of the aforementioned soft capsules containing NADH or NADPH and the soft capsules prepared by the aforementioned preparation method in the field of medicine and/or health care products.
- the content of NADH or NADPH in the soft capsule is mixed with edible vegetable oil or/and edible alcohol to form a protective film on the surface of NADH or NADPH, which is effective Reduces the influence of the external environment on NADH or NADPH, makes it difficult to be degraded by gastric acid, ensures that it is absorbed and utilized by the human body in the intestine, and significantly improves the water solubility and biological activity of NADH or NADPH, which is beneficial to the absorption of NADH or NADPH, and the effect is fast , High curative effect, easy to take, easy to store and preserve, has great application prospects.
- the present invention first provides a soft capsule containing NADH or NADPH.
- the contents of the soft capsule include NADH or NADPH, as well as edible vegetable oil or/and edible alcohol.
- the quality of the edible vegetable oil or/and edible alcohol can be 1-2 times the quality of NADH or NADPH.
- the NADH or NADPH can be prepared by yeast fermentation, chemical synthesis or in vitro enzyme catalysis. It can also be prepared by whole-enzyme catalysis in vitro.
- This preparation method is a non-chemical synthesis method that can be achieved by an in vitro enzyme-catalyzed reaction. It mainly includes the following three steps: (1) cloning and expressing related enzymes; (2) Enzyme separation, purification or/and immobilization; (3) Enzymes are obtained after interacting with raw materials (ie, catalytic reactions) under normal temperature and pressure.
- the NADH or NADPH prepared by the in vitro holoenzyme catalysis method has the advantages of high purity, no organic solvent residue, no chirality problem, and the preparation is the same type as the body.
- a protective film can be formed on the periphery of NADH or NADPH to form a coating effect on NADH or NADPH, so as to reduce the influence of external environment on NADH or NADPH and effectively avoid NADH Or the destruction of the molecular structure of NADPH reduces its activity and improves the chemical stability of NADH or NADPH.
- the edible vegetable oil includes but is not limited to at least one of linseed oil, olive oil, medium-chain triglycerides, coconut oil, or camellia seed oil.
- the edible alcohols include but are not limited to at least one of xylitol, maltitol or mannitol. These are the vegetable oils and sugar alcohol varieties commonly eaten by humans, with low cost, safety and no side effects, and are resistant to NADH or The effect of NADPH has no effect.
- the content in the soft capsule may also include antioxidants, the mass of which is 2-5 times the mass of NADH or NADPH.
- the antioxidant can be rosemary, which has the characteristics of good thermal stability, low production cost and natural non-toxicity. It has a strong inhibitory effect on the oxidation of various vegetable oils: on the one hand, it can prevent the oxidation of the protective film to ensure The protective effect of the protective film on NADH or NADPH; on the other hand, it is also conducive to the preservation and storage of soft capsules and improves the service life of soft capsules.
- the contents of the soft capsule may also include a fat-soluble antacid, the quality of which is 2-10 times that of NADH or NADPH, which can weaken the digestive effect of the acidity in the stomach on the soft capsule when the soft capsule passes through the human stomach , To prevent NADH or NADPH from losing activity due to gastric acid.
- the fat-soluble antacid can be selected from fatty acid salts, such as sodium stearate, calcium stearate or zinc stearate, preferably calcium stearate.
- the soft capsule containing NADH or NADPH of the present invention also includes a capsule shell molding material.
- the capsule shell molding material can be made of polymer materials, or alginate, or a combination of polymer materials and alginate. Conducive to the formation of the capsule shell.
- the amount of alginate used in combination is 0.5%-30% of the mass of the polymer material.
- the polymer material can be chitosan, cyclodextrin, or konjac glucomannan and its derivatives, and the konjac glucomannan and its derivatives can be konjac glucomannan, quaternary ammonium At least one of konjac glucomannan, carboxymethyl konjac glucomannan, or deacetyl konjac glucomannan.
- the alginate may be at least one of potassium alginate, sodium alginate or/and at least one of polyethylene glycol alginate.
- a protective film can be formed on the outer surface of NADH or NADPH, which can make NADH or NADPH in During the preparation process, the influence of light, air, moisture, processing, etc. on it is avoided, and the instability caused by the influence of the external environment on NADH or NADPH is effectively reduced.
- supplemented with antioxidants on the basis of the above-mentioned protective film can avoid oxidation of the oily protective film.
- the added fat-soluble antacid can further resist gastric acid and other environmental erosion before the drug enters the intestine, so that the soft capsule can enter the human stomach.
- NADH or NADPH has a protective film on the outer surface, which is also conducive to the preservation and storage of soft capsules, which has great application prospects.
- the present invention also provides a method for preparing the above-mentioned soft capsules containing NADH or NADPH, which includes the following steps:
- the edible vegetable oil or/and edible alcohol are stirred and heated to melt, which can remove impurities and precipitates in the vegetable oil and edible alcohol, and can make the vegetable oil and edible alcohol have a better dispersion effect, and stir and mix with NADH or NADPH After that, it can ensure the uniform formation of a protective film on the outer surface of NADH or NADPH.
- step S1 the method of the present invention may further include the following steps:
- NADH or NADPH is first mixed with fat-soluble antacid, so that NADH or NADPH can be uniformly attached to the antacid powder, which can resist the erosion of the external acidic environment and is also beneficial to edible vegetable oil or/and edible alcohol Formation of protective film.
- antioxidants can also be added, and the antioxidants can be added when NADH or NADPH is stirred and mixed with vegetable oil or/and edible alcohol.
- the water and the polymer material can be mixed and stirred for 10-30 minutes, and then vacuumed and degassed with a vacuum degree of ⁇ -0.07MPa to obtain a colorless glue.
- the alginate and water can be heated to 75-80°C, and after melting, vacuumize and degas, with a vacuum degree of "-0.07MPa, to obtain a colorless glue solution.
- the alginate and water can be heated to 75-80°C, melted and then mixed with the polymer materials and stirred for 10-30 minutes, and then vacuum degassed. Vacuum degree "-0.07MPa, get colorless glue liquid.
- the glue can be toned.
- the amount of pigment added can be selected according to the desired capsule color and pigment depth.
- the light-shielding agent is a common light-shielding agent known to those skilled in the art, such as titanium dioxide.
- step S5 The mixed liquid in step S1 and the glue liquid in step S4 (or the glue liquid after color mixing) are prepared by a capsule machine to prepare soft capsules, which are shaped and dried, inspected and packaged.
- the above soft capsules containing NADH or NADPH and the soft capsules prepared by the above preparation method can be widely used in the field of medicine and/or health care products, effectively solving the existing defects of NADH or NADPH that are intolerant to acid, easy to oxidize, and have low bioavailability. This not only guarantees the effective ingredients and curative effects of NADH or NADPH, but also brings convenience to users, and further prevents cross-infection.
- step S6 the raw material mixture obtained in step S1 and the toned glue are used in a capsule making machine to prepare soft capsules.
- S7 puts the soft capsule in an environment with a temperature of 25°C and a humidity of 30%, and uses a measuring ruler to detect the rubber thickness.
- S8 will shape the soft capsules and dry them at a temperature of 25°C and a humidity of 30%.
- S9 manually picks pills, removes special-shaped pills, large and small pills, bubble pills, deflated pills, etc. Then, after the soft capsules are dried, they are boxed, labeled, and boxed.
- S6 Mix 3 parts of pigment with 1 part of appropriate amount of sodium alginate and 5 parts of water, and then grind with colloid. After grinding, pour into the glue liquid and mix evenly, to color the glue liquid, and add an appropriate amount of light shielding agent to avoid light.
- step S8 The raw material mixture obtained in step S2 and the toned glue are used in a capsule machine to prepare soft capsules.
- S9 Put the soft capsule in an environment with a temperature of 20°C and a humidity of 25%, and measure the rubber thickness with a measuring ruler.
- S6 Mix 1 part of pigment with 1 part of appropriate amount of sodium alginate and 5 parts of water, and then grind with colloid. After grinding, pour into the glue liquid and mix evenly, to color the glue liquid, and add an appropriate amount of light shielding agent to avoid light.
- step S8 The raw material mixture obtained in step S2 and the toned glue are used in a capsule machine to prepare soft capsules.
- S9 Put the soft capsule in an environment with a temperature of 30°C and a humidity of 30%, and measure the rubber thickness with a measuring ruler.
- step S7 The raw material mixture obtained in step S1 and the toned glue are used in a capsule making machine to prepare soft capsules.
- S8 Put the soft capsule in an environment with a temperature of 25°C and a humidity of 30%, and measure the rubber thickness with a measuring ruler.
- S10 manually picks pills, removes special-shaped pills, large and small pills, bubble pills, deflated pills, etc. Then, after the soft capsules are dried, they are boxed, labeled, and boxed.
Abstract
A soft capsule containing NADH or NADPH, a preparation method and an application thereof in the field of medicine and health products. The content therein comprises NADH or NADPH and edible vegetable oil and/or edible glycol, wherein the mass of the edible vegetable oil and/or the edible glycol is 1-2 times that of NADH or NADPH. The content also comprises an antioxidant or/and liposoluble antacid.
Description
本发明属于医药技术及保健食品技术领域,特别涉及一种含NADH或NADPH的软胶囊及其制备方法和应用。The invention belongs to the field of medical technology and health food technology, and particularly relates to a soft capsule containing NADH or NADPH, and a preparation method and application thereof.
烟酰胺-腺嘌呤二核苷酸(NADH)
和烟酰胺-腺嘌呤-磷酸-二核苷酸(NADPH)
是一种人体内的生理物质,存在于包括人类细胞在内的所有活细胞中。这些物质是很多酶的辅助因子,而这些酶大部分都可催化氧化-还原反应。
Nicotinamide-Adenine Dinucleotide (NADH) And nicotinamide-adenine-phosphate-dinucleotide (NADPH) It is a physiological substance in the human body and exists in all living cells including human cells. These substances are cofactors of many enzymes, and most of these enzymes can catalyze oxidation-reduction reactions.
NADH或NADPH参与人体内上千种生理代谢反应,在基因修复、提高免疫力、抗氧化、改善睡眠等方面起到重要作用,充足的NADH或NADPH能让身体受到更好的保护,少发生健康问题,预防和控制疾病,而体外补充NADH或NADPH有利于促进身体各种生理机能保持最佳状态。但是NADH或NADPH是生物形式的氢,极其不稳定,光照、酸性环境或者遇到空气中的氧气、水分都会破坏NADH或NADPH的分子结构。长久以来,NADH或NADPH主要通过输液和片剂的方式进行使用,而且由于其化学不稳定性,输液还需要新鲜制备,制备过程中也难以保证其活性,片剂虽然制备简单,但是制剂过程需要加入较多赋形剂,而且生物利用度不高。NADH or NADPH participates in thousands of physiological and metabolic reactions in the human body, and plays an important role in gene repair, immunity enhancement, anti-oxidation, and sleep improvement. Adequate NADH or NADPH can make the body better protected and less healthy. Problems, prevention and control of diseases, and supplementation of NADH or NADPH in vitro is beneficial to promote various physiological functions of the body to maintain the best condition. However, NADH or NADPH is a biological form of hydrogen, which is extremely unstable. Light, acidic environment, or oxygen and moisture in the air will destroy the molecular structure of NADH or NADPH. For a long time, NADH or NADPH was mainly used in the form of infusion and tablets, and due to its chemical instability, the infusion needed to be prepared fresh, and it was difficult to ensure its activity during the preparation process. Although the preparation of tablets is simple, the preparation process requires Add more excipients, and the bioavailability is not high.
因此,怎样解决NADH或NADPH不稳定的缺陷,制备一种性状稳定,杂质少,生物利用度高的口服剂型是目前研究的难点。Therefore, how to solve the instability of NADH or NADPH and prepare an oral dosage form with stable properties, less impurities, and high bioavailability is the current research difficulty.
本发明的目的在于克服上述现有技术的不足,首先提供了一种含NADH或NADPH的软胶囊。The purpose of the present invention is to overcome the above-mentioned shortcomings of the prior art, and firstly provides a soft capsule containing NADH or NADPH.
本发明提供了一种含NADH或NADPH的软胶囊,所述软胶囊内的容纳物包括NADH或NADPH以及食用植物油或/和可食用醇,所述食用植物油或/和可食用醇的质量为所述NADH或NADPH质量的1-2倍。The present invention provides a soft capsule containing NADH or NADPH. The contents of the soft capsule include NADH or NADPH and edible vegetable oil or/and edible alcohol. The quality of the edible vegetable oil or/and edible alcohol is determined Said NADH or NADPH quality 1-2 times.
本发明还提供了上述含NADH或NADPH的软胶囊的制备方法,包括下述步骤:The present invention also provides a method for preparing the above-mentioned soft capsules containing NADH or NADPH, which includes the following steps:
将食用植物油或/和可食用醇搅拌加热熔融,冷却后,再将NADH或NADPH与所述食用植物油或/和可食用醇搅拌混合均匀,研磨、过筛后得到原料混合液;Stir and melt the edible vegetable oil or/and edible alcohol, and after cooling, stir and mix NADH or NADPH with the edible vegetable oil or/and edible alcohol evenly, and obtain a raw material mixture after grinding and sieving;
将水与胶囊外壳成型原料搅拌混合均匀,抽真空脱气,得到无色胶液; Stir and mix the water and the capsule shell forming materials evenly, vacuum and degas to obtain a colorless glue;
用粘度仪检测胶液粘度达到10000mPa.s以上时,将胶液降温;When the viscosity of the glue liquid reaches 10000mPa.s or more by the viscometer, the glue liquid is cooled down;
将降温后的胶液过筛;Sieve the cooled glue;
将所述原料混合液与过筛后所述的胶液用制胶囊机制备软胶囊,定型、干燥。The raw material mixture and the sieved glue are used to prepare soft capsules with a capsule making machine, which is shaped and dried.
本发明提供的上述含NADH或NADPH的软胶囊的制备方法,制备工艺简单,容易实现,进一步提高了NADH或NADPH生物利用度及服用效果。The preparation method of the above-mentioned NADH or NADPH-containing soft capsule provided by the present invention has a simple preparation process and is easy to realize, and further improves the bioavailability and administration effect of NADH or NADPH.
本发明还提供了上述所述的含NADH或NADPH的软胶囊以及上述所述的制备方法制备的软胶囊在药物和/或保健品领域的应用。The present invention also provides the application of the aforementioned soft capsules containing NADH or NADPH and the soft capsules prepared by the aforementioned preparation method in the field of medicine and/or health care products.
本发明提供的上述以NADH或NADPH为主要有效成分的软胶囊中,其软胶囊中的容纳物 NADH或NADPH与食用植物油或/和可食用醇混合,可使NADH或NADPH表面形成保护膜,有效降低了外界环境对NADH或NADPH的影响,使其不易被胃酸降解,保障其在肠道被人体吸收利用,显著提高了NADH或NADPH的水溶性和生物活性,有利于NADH或NADPH吸收,显效快、疗效高,易服用,便于贮藏和保存,具有很大应用前景。In the above-mentioned soft capsule with NADH or NADPH as the main active ingredient provided by the present invention, the content of NADH or NADPH in the soft capsule is mixed with edible vegetable oil or/and edible alcohol to form a protective film on the surface of NADH or NADPH, which is effective Reduces the influence of the external environment on NADH or NADPH, makes it difficult to be degraded by gastric acid, ensures that it is absorbed and utilized by the human body in the intestine, and significantly improves the water solubility and biological activity of NADH or NADPH, which is beneficial to the absorption of NADH or NADPH, and the effect is fast , High curative effect, easy to take, easy to store and preserve, has great application prospects.
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the objectives, technical solutions, and advantages of the present invention clearer, the following further describes the present invention in detail with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described here are only used to explain the present invention, but not to limit the present invention.
本发明首先提供了一种含NADH或NADPH的软胶囊,软胶囊中的容纳物包括NADH或NADPH,还包括食用植物油或/和可食用醇,其中食用植物油或/和可食用醇的质量可为NADH或NADPH质量的1-2倍。The present invention first provides a soft capsule containing NADH or NADPH. The contents of the soft capsule include NADH or NADPH, as well as edible vegetable oil or/and edible alcohol. The quality of the edible vegetable oil or/and edible alcohol can be 1-2 times the quality of NADH or NADPH.
所述NADH或NADPH可通过酵母菌发酵、化学合成或者体外酶催化的方式制备得到。还可以采用体外全酶催化的方式制备,这种制备方法是一种非化学合成方法,完全可以通过离体酶催化反应实现,其主要包括如下三个步骤:(1)克隆和表达相关酶;(2)酶分离、纯化或/和固定化;(3)酶在常温常压下与原料相互作用(即催化反应)后得到。通过该体外全酶催化方式制备得到的NADH或NADPH具有纯度高、不含有机溶剂残留、不存在手性问题且制备出的是和机体内同型等优点。The NADH or NADPH can be prepared by yeast fermentation, chemical synthesis or in vitro enzyme catalysis. It can also be prepared by whole-enzyme catalysis in vitro. This preparation method is a non-chemical synthesis method that can be achieved by an in vitro enzyme-catalyzed reaction. It mainly includes the following three steps: (1) cloning and expressing related enzymes; (2) Enzyme separation, purification or/and immobilization; (3) Enzymes are obtained after interacting with raw materials (ie, catalytic reactions) under normal temperature and pressure. The NADH or NADPH prepared by the in vitro holoenzyme catalysis method has the advantages of high purity, no organic solvent residue, no chirality problem, and the preparation is the same type as the body.
当食用植物油或/和可食用醇与NADH或NADPH混合时,可在NADH或NADPH外周形成保护膜,对NADH或NADPH形成包覆作用,以减少外界环境对NADH或NADPH的影响,有效避免了NADH或NADPH的分子结构的破坏而降低其活性,提高了NADH或NADPH的化学稳定性。When edible vegetable oil or/and edible alcohol is mixed with NADH or NADPH, a protective film can be formed on the periphery of NADH or NADPH to form a coating effect on NADH or NADPH, so as to reduce the influence of external environment on NADH or NADPH and effectively avoid NADH Or the destruction of the molecular structure of NADPH reduces its activity and improves the chemical stability of NADH or NADPH.
具体地,所述食用植物油包括但不限于亚麻籽油、橄榄油、中链甘油三酯、椰子油或山茶籽油中的至少一种。所述可食用醇包括但不限于木糖醇、麦芽糖醇或甘露糖醇中的至少一种,这些都是人类生活常食用的植物油和糖醇品种,成本低,安全无副作用,且对NADH或NADPH的使用效果无任何影响。Specifically, the edible vegetable oil includes but is not limited to at least one of linseed oil, olive oil, medium-chain triglycerides, coconut oil, or camellia seed oil. The edible alcohols include but are not limited to at least one of xylitol, maltitol or mannitol. These are the vegetable oils and sugar alcohol varieties commonly eaten by humans, with low cost, safety and no side effects, and are resistant to NADH or The effect of NADPH has no effect.
进一步地,软胶囊中的容纳物还可包括抗氧化剂, 质量为NADH或NADPH质量的2-5倍。所述抗氧化剂可选用迷迭香,其具有热稳定性能好、生产成本低和天然无毒等特点,对各种植物油的氧化有强大的抑制效果:一方面可防止保护膜的氧化,以保证保护膜对NADH或NADPH的保护效果;另一方面还有利于软胶囊的保存和贮藏,提高软胶囊成品的使用期限。Further, the content in the soft capsule may also include antioxidants, the mass of which is 2-5 times the mass of NADH or NADPH. The antioxidant can be rosemary, which has the characteristics of good thermal stability, low production cost and natural non-toxicity. It has a strong inhibitory effect on the oxidation of various vegetable oils: on the one hand, it can prevent the oxidation of the protective film to ensure The protective effect of the protective film on NADH or NADPH; on the other hand, it is also conducive to the preservation and storage of soft capsules and improves the service life of soft capsules.
进一步地,软胶囊中的容纳物还可包括脂溶性抗酸剂,质量为NADH或NADPH质量的2-10倍,可在软胶囊经过人体胃部时,减弱胃内酸度对软胶囊的消化作用,避免NADH或NADPH受胃酸的影响而失去活性。所述脂溶性抗酸剂可选用脂肪酸盐,如硬脂酸钠、硬脂酸钙或硬脂酸锌,优选硬脂酸钙。Furthermore, the contents of the soft capsule may also include a fat-soluble antacid, the quality of which is 2-10 times that of NADH or NADPH, which can weaken the digestive effect of the acidity in the stomach on the soft capsule when the soft capsule passes through the human stomach , To prevent NADH or NADPH from losing activity due to gastric acid. The fat-soluble antacid can be selected from fatty acid salts, such as sodium stearate, calcium stearate or zinc stearate, preferably calcium stearate.
本发明含NADH或NADPH的软胶囊还包括胶囊外壳成型原料,所述胶囊外壳成型原料可选用高分子材料,也可选用藻酸盐,还可以是高分子材料和藻酸盐的组合使用,有利于胶囊外壳的成型。组合使用时藻酸盐用量为高分子材料质量的0.5%-30%。其中所述的高分子材料可为壳聚糖、环糊精或魔芋葡甘聚糖及其衍生物,进一步所述的魔芋葡甘聚糖及其衍生物可选用魔芋葡甘聚糖、季铵化魔芋葡甘聚糖、羧甲基魔芋葡甘聚糖或脱乙酰魔芋葡甘聚糖中的至少一种。所述的藻酸盐可选用藻酸钾、藻酸钠中的至少一种或/和聚乙二醇藻酸盐中的至少一种。这些都是制备胶囊的原料,安全无副作用,既可形成对原料的保护,又有利于胶囊的成型,还可作为基质对药物产生缓释作用,且具有抗菌、抗氧化功能。The soft capsule containing NADH or NADPH of the present invention also includes a capsule shell molding material. The capsule shell molding material can be made of polymer materials, or alginate, or a combination of polymer materials and alginate. Conducive to the formation of the capsule shell. The amount of alginate used in combination is 0.5%-30% of the mass of the polymer material. The polymer material can be chitosan, cyclodextrin, or konjac glucomannan and its derivatives, and the konjac glucomannan and its derivatives can be konjac glucomannan, quaternary ammonium At least one of konjac glucomannan, carboxymethyl konjac glucomannan, or deacetyl konjac glucomannan. The alginate may be at least one of potassium alginate, sodium alginate or/and at least one of polyethylene glycol alginate. These are the raw materials for the preparation of capsules, which are safe and have no side effects. They can not only protect the raw materials, but also facilitate the formation of the capsule, and can also be used as a matrix to produce slow-release effects on drugs, and have antibacterial and antioxidant functions.
本发明上述含NADH或NADPH的软胶囊之容纳物中,通过将NADH或NADPH与食用植物油或/和可食用醇的混合,可在NADH或NADPH的外表面形成保护膜,可使NADH或NADPH在制备过程中避免光照、空气、水分、加工等对其产生的影响,有效降低外界环境对NADH或NADPH影响而导致的不稳定性。同时,在上述保护膜的基础上辅以抗氧化剂,可避免油性保护膜氧化,添加的脂溶性抗酸剂可以在药物进入肠道前进一步抵御胃酸等环境侵蚀,使软胶囊在进入人体胃部后使其不易被胃酸降解,可避免胃酸的影响使NADH或NADPH失去活性而导致疗效的降低,从而提高了NADH或NADPH的水溶性和生物活性,延缓了NADH或NADPH在进入人体内的释放、吸收、分布和代谢,能够保障其顺利进入肠道被人体吸收利用,显效快、疗效高,同时由于NADH或NADPH外表面具有保护膜,也有利于软胶囊的保存贮藏,具有很大应用前景。In the contents of the soft capsule containing NADH or NADPH of the present invention, by mixing NADH or NADPH with edible vegetable oil or/and edible alcohol, a protective film can be formed on the outer surface of NADH or NADPH, which can make NADH or NADPH in During the preparation process, the influence of light, air, moisture, processing, etc. on it is avoided, and the instability caused by the influence of the external environment on NADH or NADPH is effectively reduced. At the same time, supplemented with antioxidants on the basis of the above-mentioned protective film can avoid oxidation of the oily protective film. The added fat-soluble antacid can further resist gastric acid and other environmental erosion before the drug enters the intestine, so that the soft capsule can enter the human stomach. Afterwards, it is not easy to be degraded by gastric acid, which can avoid the influence of gastric acid to inactivate NADH or NADPH and reduce the curative effect, thereby improving the water solubility and biological activity of NADH or NADPH, and delaying the release of NADH or NADPH into the human body. Absorption, distribution and metabolism can ensure its smooth entry into the intestines and be absorbed and utilized by the human body. It has a fast effect and high curative effect. At the same time, NADH or NADPH has a protective film on the outer surface, which is also conducive to the preservation and storage of soft capsules, which has great application prospects.
本发明还提供了上述含NADH或NADPH的软胶囊的制备方法,包括下述步骤:The present invention also provides a method for preparing the above-mentioned soft capsules containing NADH or NADPH, which includes the following steps:
S1 将食用植物油或/和可食用醇搅拌加热至70-80℃熔融,然后冷却至35-45℃,再按配比与NADH或NADPH搅拌混合30-60Min,研磨、过筛,得到原料混合液。S1 Stir and heat the edible vegetable oil or/and edible alcohol to 70-80°C to melt, then cool to 35-45°C, then stir and mix with NADH or NADPH according to the ratio for 30-60 Min, grind and sieve to obtain a raw material mixture.
该S1步骤将食用植物油或/和可食用醇搅拌加热熔融,可去除植物油和可食用醇中的杂质和沉淀,且可使植物油和可食用醇具有较好的分散效果,与NADH或NADPH搅拌混合后,可保证NADH或NADPH外表面均匀形成保护膜。In the S1 step, the edible vegetable oil or/and edible alcohol are stirred and heated to melt, which can remove impurities and precipitates in the vegetable oil and edible alcohol, and can make the vegetable oil and edible alcohol have a better dispersion effect, and stir and mix with NADH or NADPH After that, it can ensure the uniform formation of a protective film on the outer surface of NADH or NADPH.
本发明方法在上述步骤S1之前,还可包括下述步骤:Before step S1, the method of the present invention may further include the following steps:
S0 将NADH或NADPH先与脂溶性抗酸剂按配比混合均匀、过筛,得到混合物A,然后再使所述混合物A与加热熔融冷却后的食用植物油或/和可食用醇搅拌混合30-60Min,研磨、过筛后得到原料混合液。S0 First mix NADH or NADPH with fat-soluble antacid according to the ratio and sieving to obtain mixture A, and then stir and mix said mixture A with edible vegetable oil or/and edible alcohol after heating, melting and cooling for 30-60Min After grinding and sieving, the raw material mixture is obtained.
该步骤将NADH或NADPH先与脂溶性抗酸剂混合,可使NADH或NADPH均匀附着于抗酸剂粉体上,既可以抵御外界酸性环境的侵蚀,又有利于食用植物油或/和可食用醇保护膜的形成。In this step, NADH or NADPH is first mixed with fat-soluble antacid, so that NADH or NADPH can be uniformly attached to the antacid powder, which can resist the erosion of the external acidic environment and is also beneficial to edible vegetable oil or/and edible alcohol Formation of protective film.
本发明在S0步骤和/或S1步骤中,还可加入抗氧化剂,所述抗氧化剂可在NADH或NADPH与植物油或/和可食用醇搅拌混合时加入。In the present invention, in step S0 and/or step S1, antioxidants can also be added, and the antioxidants can be added when NADH or NADPH is stirred and mixed with vegetable oil or/and edible alcohol.
S2 将水与胶囊外壳成型原料混合搅拌10-30min后,抽真空脱气,真空度《-0.07MPa,得到无色胶液。S2 After mixing and stirring the water and the capsule shell forming materials for 10-30 minutes, vacuumize and degas, with a vacuum degree of "-0.07MPa, to obtain a colorless glue solution.
该步骤中:In this step:
当胶囊外壳成型原料选用高分子材料时,可将水与高分子材料时混合搅拌10-30min后,抽真空脱气,真空度《-0.07MPa,得到无色胶液。When a polymer material is used as the raw material for the capsule shell molding, the water and the polymer material can be mixed and stirred for 10-30 minutes, and then vacuumed and degassed with a vacuum degree of <-0.07MPa to obtain a colorless glue.
当胶囊外壳成型原料选用藻酸盐时,可将藻酸盐与水加热至75-80℃,融化后抽真空脱气,真空度《-0.07MPa,得到无色胶液。When alginate is used as the raw material for the capsule shell molding, the alginate and water can be heated to 75-80°C, and after melting, vacuumize and degas, with a vacuum degree of "-0.07MPa, to obtain a colorless glue solution.
当胶囊外壳成型原料选用藻酸盐和高分子材料组合时,可先将藻酸盐与水加热至75-80℃,融化后再和高分子材料混合搅拌10-30min后,抽真空脱气,真空度《-0.07MPa,得到无色胶液。When the raw material of the capsule shell is formed by using a combination of alginate and polymer materials, the alginate and water can be heated to 75-80°C, melted and then mixed with the polymer materials and stirred for 10-30 minutes, and then vacuum degassed. Vacuum degree "-0.07MPa, get colorless glue liquid.
S3 用粘度仪检测胶液粘度达到10000mPa.s以上时,将胶液温度降至65℃左右。S3 When the viscosity of the glue is detected by the viscometer to reach 10000mPa.s or more, the temperature of the glue is reduced to about 65°C.
S4 将胶液过筛,在温度60±2℃保存。S4 Pass the glue through a sieve and store at a temperature of 60±2°C.
该步骤中,若需要形成有颜色的软胶囊,可将胶液进行调色。将食用色素与适量藻酸钠混合,采用胶体磨研磨后加入胶液后混合均匀。所加入的色素的量可根据需要的胶囊颜色和色素深度进行选择。In this step, if a colored soft capsule needs to be formed, the glue can be toned. Mix the food coloring with an appropriate amount of sodium alginate, grind it with a colloid mill, add the glue, and mix well. The amount of pigment added can be selected according to the desired capsule color and pigment depth.
本发明软胶囊制备时,还可适量可加入避光剂避光。所述避光剂为本领域技术人员所习知的常用避光剂,如二氧化钛。When preparing the soft capsule of the present invention, an appropriate amount of light-shielding agent can be added to prevent light. The light-shielding agent is a common light-shielding agent known to those skilled in the art, such as titanium dioxide.
胶液调色后搅拌40Min,60±2℃保温备用。After mixing the glue, stir it for 40 minutes and keep it at 60±2℃ for later use.
S5 将S1步骤中的混合液与S4步骤中的胶液(或调色后的胶液)用制胶囊机制备软胶囊,定型、干燥后,检验、包装。S5 The mixed liquid in step S1 and the glue liquid in step S4 (or the glue liquid after color mixing) are prepared by a capsule machine to prepare soft capsules, which are shaped and dried, inspected and packaged.
上述含有NADH或NADPH的软胶囊以及采用上述制备方法制备的软胶囊可在药物和/或保健品领域广泛应用,有效解决了现有NADH或NADPH不耐酸,易氧化,生物利用度低的缺陷,这样不仅保证了NADH或NADPH的有效成分及疗效,还为使用者带来了方便,进一步还可避免交叉感染。The above soft capsules containing NADH or NADPH and the soft capsules prepared by the above preparation method can be widely used in the field of medicine and/or health care products, effectively solving the existing defects of NADH or NADPH that are intolerant to acid, easy to oxidize, and have low bioavailability. This not only guarantees the effective ingredients and curative effects of NADH or NADPH, but also brings convenience to users, and further prevents cross-infection.
下面结合实施例进一步说明上述含NADH或NADPH的软胶囊时的制备方法。The following examples further illustrate the preparation method of the soft capsules containing NADH or NADPH.
实施例Example
11
::
S1 将亚麻籽油50份,搅拌加热至80℃熔融,再搅拌冷却至约40℃;然后将NADH或NADPH30份与冷却后的亚麻籽油搅拌混合60Min,研磨,过100目筛后得到原料混合液。S1 Mix 50 parts of linseed oil, stir and heat to 80°C to melt, then stir and cool to about 40°C; then stir and mix 30 parts of NADH or NADPH with the cooled linseed oil for 60 minutes, grind, and pass through a 100 mesh sieve to obtain the raw material mixture liquid.
S2 将藻酸钠3份与水加热至80℃,融化,再与魔芋葡甘聚糖10份混合,搅拌30min后,抽真空脱气,真空度《-0.07MPa,得到无色胶液。S2 Heat 3 parts of sodium alginate with water to 80°C, melt, and then mix with 10 parts of konjac glucomannan. After stirring for 30 minutes, vacuumize and degas with a vacuum degree of "-0.07MPa to obtain a colorless glue solution.
S3 用粘度仪检测胶液粘度达到10000mPa.s以上时,将胶液温度降至65℃左右。S3 When the viscosity of the glue is detected by the viscometer to reach 10000mPa.s or more, the temperature of the glue is reduced to about 65°C.
S4 将胶液过100目筛,在温度60±2℃下保存。S4 Pass the glue through a 100-mesh sieve and store it at a temperature of 60±2°C.
S5将食用色素2份与适量藻酸钠1份和水5份混合,再用胶体研磨,研磨后倒入胶液中混合均匀,对胶液进行调色。胶液调色后搅拌40Min,60±2℃保温备用。In S5, mix 2 parts of food coloring with 1 part of sodium alginate and 5 parts of water, then grind with colloid, pour into glue liquid and mix evenly after grinding, and color glue liquid. After mixing the glue, stir it for 40 minutes and keep it at 60±2℃ for later use.
进一步地,在调色后的胶液中加入适量市场上常用的避光剂,如二氧化钛,避光。Furthermore, an appropriate amount of light-shielding agent commonly used in the market, such as titanium dioxide, is added to the glue solution after toning to avoid light.
S6将S1步骤得到的原料混合液与调色后的胶液用制胶囊机制备软胶囊。In S6, the raw material mixture obtained in step S1 and the toned glue are used in a capsule making machine to prepare soft capsules.
S7将软胶囊至于温度25℃,湿度30%的环境内,用测量尺检测胶皮厚度。S7 puts the soft capsule in an environment with a temperature of 25°C and a humidity of 30%, and uses a measuring ruler to detect the rubber thickness.
S8将软胶囊定型,在温度25℃、湿度30%条件下,干燥。S8 will shape the soft capsules and dry them at a temperature of 25°C and a humidity of 30%.
S9人工拣丸,剔除异型丸、大小丸、气泡丸、瘪丸等,然后对拣丸后的软胶囊进行干燥后,装盒,贴签,装箱。S9 manually picks pills, removes special-shaped pills, large and small pills, bubble pills, deflated pills, etc. Then, after the soft capsules are dried, they are boxed, labeled, and boxed.
实施例Example
22
::
S1 将NADH或NADPH20份与抗酸剂硬脂酸钙60份混合均匀,过100目筛,得到混合物A。S1 Mix 20 parts of NADH or NADPH and 60 parts of antacid calcium stearate uniformly, and pass through a 100-mesh sieve to obtain mixture A.
S2将木糖醇40份搅拌加热至75℃熔融,再搅拌冷却至约40℃;然后将混合物A与冷却后的木糖醇搅拌混合40Min,研磨,过100目筛后得到原料混合液。S2 Stir and heat 40 parts of xylitol to 75°C to melt, and then stir and cool to about 40°C; then stir and mix the mixture A with the cooled xylitol for 40Min, grind, and pass through a 100 mesh sieve to obtain a raw material mixture.
S3 将壳聚糖20份与水20份混合,搅拌30min后,抽真空脱气,真空度《-0.07MPa,得到无色胶液。S3 Mix 20 parts of chitosan with 20 parts of water, and after stirring for 30 minutes, vacuumize and degas, with a vacuum degree of "-0.07MPa, to obtain a colorless glue solution.
S4 用粘度仪检测胶液粘度达到10000mPa.s以上时,将胶液温度降至65℃左右。S4 When the viscosity of the glue is detected by a viscometer to reach more than 10000mPa.s, the temperature of the glue is reduced to about 65°C.
S5 将胶液过100目筛,在温度60±2℃下保存。S5 Pass the glue through a 100-mesh sieve and store it at a temperature of 60±2°C.
S6将色素3份与适量藻酸钠1份和水5份混合,再用胶体研磨,研磨后倒入胶液中混合均匀,对胶液进行调色,并适量加入避光剂避光。S6 Mix 3 parts of pigment with 1 part of appropriate amount of sodium alginate and 5 parts of water, and then grind with colloid. After grinding, pour into the glue liquid and mix evenly, to color the glue liquid, and add an appropriate amount of light shielding agent to avoid light.
S7 胶液调色后搅拌50Min,60±2℃保温备用。After mixing the S7 glue, stir it for 50 minutes, and keep it at 60±2℃ for later use.
S8 将S2步骤得到的原料混合液与调色后的胶液用制胶囊机制备软胶囊。S8 The raw material mixture obtained in step S2 and the toned glue are used in a capsule machine to prepare soft capsules.
S9 将软胶囊至于温度20℃,湿度25%的环境内,用测量尺检测胶皮厚度。S9 Put the soft capsule in an environment with a temperature of 20°C and a humidity of 25%, and measure the rubber thickness with a measuring ruler.
S10、将软胶囊定型,在温度20℃、湿度25%条件下,干燥。S10. Shape the soft capsule and dry it at a temperature of 20°C and a humidity of 25%.
S11 人工拣丸,剔除异型丸、大小丸、气泡丸、瘪丸等,然后对拣丸后的软胶囊进行干燥后,装盒,贴签,装箱。S11 Manually pick pills, remove special-shaped pills, large and small pills, bubble pills, collapsed pills, etc., and then dry the soft capsules after picking the pills, pack them into boxes, label them, and pack them.
实施例Example
33
::
S1 将NADH或NADPH40份与抗酸剂硬脂酸钠200份混合均匀,过100目筛,得到混合物A。S1 Mix 40 parts of NADH or NADPH and 200 parts of antacid sodium stearate evenly, and pass through a 100-mesh sieve to obtain mixture A.
S2将中链甘油三酯60份搅拌加热至70℃熔融,再搅拌冷却至约40℃;然后将混合物A与冷却后的中链甘油三酯搅拌混合40Min,研磨,过100目筛后得到原料混合液。S2 Stir and heat 60 parts of medium chain triglycerides to 70°C to melt, and then stir and cool to about 40°C; then stir and mix mixture A and the cooled medium chain triglycerides for 40 minutes, grind, and pass through a 100 mesh sieve to obtain the raw material Mixture.
S3 将藻酸钾10份与水30份加热至80℃,融化,再与羧甲基魔芋葡甘聚糖40份混合,搅拌25min后,抽真空脱气,真空度《-0.07MPa,得到无色胶液。S3 Heat 10 parts of potassium alginate and 30 parts of water to 80℃, melt, and then mix with 40 parts of carboxymethyl konjac glucomannan, stir for 25 minutes, vacuum and degas, vacuum degree "-0.07MPa, get no Color glue liquid.
S4 用粘度仪检测胶液粘度达到10000mPa.s以上时,将胶液温度降至65℃左右。S4 When the viscosity of the glue is detected by the viscometer to reach more than 10000mPa.s, the temperature of the glue is reduced to about 65°C.
S5 将胶液过100目筛,在温度60±2℃下保存。S5 Pass the glue through a 100-mesh sieve and store it at a temperature of 60±2°C.
S6将色素1份与适量藻酸钠1份和水5份混合,再用胶体研磨,研磨后倒入胶液中混合均匀,对胶液进行调色,并适量加入避光剂避光。S6 Mix 1 part of pigment with 1 part of appropriate amount of sodium alginate and 5 parts of water, and then grind with colloid. After grinding, pour into the glue liquid and mix evenly, to color the glue liquid, and add an appropriate amount of light shielding agent to avoid light.
S7 胶液调色后搅拌45Min,60±2℃保温备用。After mixing the S7 glue, stir it for 45min, keep it at 60±2℃ for later use.
S8 将S2步骤得到的原料混合液与调色后的胶液用制胶囊机制备软胶囊。S8 The raw material mixture obtained in step S2 and the toned glue are used in a capsule machine to prepare soft capsules.
S9 将软胶囊至于温度30℃,湿度30%的环境内,用测量尺检测胶皮厚度。S9 Put the soft capsule in an environment with a temperature of 30°C and a humidity of 30%, and measure the rubber thickness with a measuring ruler.
S10、将软胶囊定型,在温度30℃,湿度30%,干燥。S10. Shape the soft capsule and dry it at a temperature of 30°C and a humidity of 30%.
S11 人工拣丸,剔除异型丸、大小丸、气泡丸、瘪丸等,然后对拣丸后的软胶囊进行干燥后,装盒,贴签,装箱。S11 Manually pick pills, remove special-shaped pills, large and small pills, bubble pills, collapsed pills, etc., and then dry the soft capsules after picking the pills, pack them into boxes, label them, and pack them.
实施例Example
44
::
S1 将山茶籽油100份搅拌加热至75℃熔融,再搅拌冷却至约40℃;然后将NADH或NADPH80份与冷却后的山茶籽油搅拌混合45Min,再加入迷迭香200份,研磨,过100目筛后得到原料混合液。S1 Stir and heat 100 parts of camellia seed oil to 75°C to melt, then stir and cool to about 40°C; then stir and mix 80 parts of NADH or NADPH with the cooled camellia seed oil for 45 minutes, then add 200 parts of rosemary, grind, and pass After a 100-mesh sieve, a raw material mixture is obtained.
S2 将藻酸钠15份与水15份加热至80℃,融化,再与环糊精50份混合,搅拌30min抽真空脱气,真空度《-0.07MPa,得到无色胶液。S2 Heat 15 parts of sodium alginate and 15 parts of water to 80°C, melt, and then mix with 50 parts of cyclodextrin, stir for 30 minutes, vacuum and degas, vacuum degree "-0.07MPa, to obtain colorless glue liquid.
S3 用粘度仪检测胶液粘度达到10000mPa.s以上时,将胶液温度降至65℃左右。S3 When the viscosity of the glue liquid reaches 10000mPa.s or more by the viscometer, the glue liquid temperature is reduced to about 65°C.
S4 将胶液过100目筛,在温度60±2℃下保存。S4 Pass the glue through a 100-mesh sieve and store it at a temperature of 60±2℃.
S5将色素2份与适量藻酸钠2份和水5份混合,再用胶体研磨,研磨后倒入胶液中混合均匀,对胶液进行调色,并适量加入避光剂避光。In S5, mix 2 parts of pigment with 2 parts of sodium alginate and 5 parts of water, then grind with colloid, pour into glue liquid and mix evenly after grinding, to color glue liquid, and add appropriate amount of light shielding agent to avoid light.
S6 胶液调色后搅拌40Min,60±2℃保温备用。After mixing the S6 glue, stir it for 40 minutes and keep it at 60±2℃ for later use.
S7 将S1步骤得到的原料混合液与调色后的胶液用制胶囊机制备软胶囊。S7 The raw material mixture obtained in step S1 and the toned glue are used in a capsule making machine to prepare soft capsules.
S8 将软胶囊至于温度25℃,湿度30%的环境内,用测量尺检测胶皮厚度。S8 Put the soft capsule in an environment with a temperature of 25°C and a humidity of 30%, and measure the rubber thickness with a measuring ruler.
S9、将软胶囊定型,在温度25℃,湿度30%,干燥。S9. Shape the soft capsule and dry it at a temperature of 25°C and a humidity of 30%.
S10人工拣丸,剔除异型丸、大小丸、气泡丸、瘪丸等,然后对拣丸后的软胶囊进行干燥后,装盒,贴签,装箱。S10 manually picks pills, removes special-shaped pills, large and small pills, bubble pills, deflated pills, etc. Then, after the soft capsules are dried, they are boxed, labeled, and boxed.
本发明的上述实施例所示仅为本发明较佳实施例之部分,并不能以此局限本发明,在不脱离本发明精髓的条件下,本领域技术人员所作的任何修改、等同替换和改进等,都属本发明的保护范围。The above-mentioned embodiments of the present invention are only part of the preferred embodiments of the present invention, and cannot be used to limit the present invention. Any modification, equivalent replacement and improvement made by those skilled in the art without departing from the essence of the present invention Etc., all belong to the protection scope of the present invention.
Claims (10)
- 一种含NADH或NADPH的软胶囊,其特征在于,所述软胶囊内的容纳物包括NADH或NADPH以及食用植物油或/和可食用醇,所述食用植物油或/和可食用醇的质量为所述NADH或NADPH质量的1-2倍。A soft capsule containing NADH or NADPH, characterized in that the contents in the soft capsule include NADH or NADPH and edible vegetable oil or/and edible alcohol, and the quality of the edible vegetable oil or/and edible alcohol is determined Said NADH or NADPH quality 1-2 times.
- 如权利要求1所述的含NADH或NADPH的软胶囊,其特征在于,所述食用植物油包括但不限于亚麻籽油、橄榄油、中链甘油三酯、椰子油或山茶籽油中的至少一种;所述可食用醇包括但不限于木糖醇、麦芽糖醇或甘露糖醇中的至少一种。The soft capsule containing NADH or NADPH according to claim 1, wherein the edible vegetable oil includes but not limited to at least one of linseed oil, olive oil, medium-chain triglycerides, coconut oil or camellia seed oil Species; the edible alcohol includes but is not limited to at least one of xylitol, maltitol or mannitol.
- 如权利要求1所述的含NADH或NADPH的软胶囊,其特征在于,所述软胶囊内的容纳物还包括抗氧化剂,所述抗氧化剂的质量为所述NADH或NADPH质量的2-5倍。The soft capsule containing NADH or NADPH according to claim 1, wherein the content in the soft capsule further comprises an antioxidant, and the quality of the antioxidant is 2-5 times the weight of the NADH or NADPH .
- 如权利要求3所述的含NADH或NADPH的软胶囊,其特征在于,所述抗氧化剂包括但不限于迷迭香。The soft capsule containing NADH or NADPH according to claim 3, wherein the antioxidant includes but not limited to rosemary.
- 如权利要求1-4任一项所述的含NADH或NADPH的软胶囊,其特征在于,所述软胶囊内的容纳物还包括脂溶性抗酸剂,所述脂溶性抗酸剂的质量为所述NADH或NADPH质量的2-10倍。The soft capsule containing NADH or NADPH according to any one of claims 1 to 4, wherein the content in the soft capsule further comprises a fat-soluble antacid, and the quality of the fat-soluble antacid is The quality of NADH or NADPH is 2-10 times.
- 如权利要求5所述的含NADH或NADPH的软胶囊,其特征在于,所述脂溶性抗酸剂为脂肪酸盐,所述脂肪酸盐包括但不限于硬脂酸钠、硬脂酸钙或硬脂酸锌。The soft capsule containing NADH or NADPH according to claim 5, wherein the fat-soluble antacid is a fatty acid salt, and the fatty acid salt includes but is not limited to sodium stearate, calcium stearate or Zinc stearate.
- 如权利要求1所述的含NADH或NADPH的软胶囊,其特征在于,所述软胶囊包括胶囊外壳成型原料,所述胶囊外壳成型原料包括高分子材料或/和藻酸盐,其中所述高分子材料包括但不限于壳聚糖、环糊精或魔芋葡甘聚糖及其衍生物;所述藻酸盐包括但不限于藻酸钾、藻酸钠中的至少一种或/和聚乙二醇藻酸盐中的至少一种;所述藻酸盐质量为所述高分子材料的质量的0.5%-30%。The soft capsule containing NADH or NADPH according to claim 1, wherein the soft capsule includes a capsule shell molding material, and the capsule shell molding material includes a polymer material or/and alginate, wherein the high Molecular materials include but are not limited to chitosan, cyclodextrin or konjac glucomannan and their derivatives; the alginate includes but is not limited to at least one of potassium alginate, sodium alginate or/and polyethylene At least one of glycol alginate; the mass of the alginate is 0.5%-30% of the mass of the polymer material.
- 如权利要求7所述的含NADH或NADPH的软胶囊,其特征在于,所述魔芋葡甘聚糖及其衍生物为魔芋葡甘聚糖、季铵化魔芋葡甘聚糖、羧甲基魔芋葡甘聚糖或脱乙酰魔芋葡甘聚糖中的至少一种。The soft capsule containing NADH or NADPH according to claim 7, wherein the konjac glucomannan and its derivatives are konjac glucomannan, quaternized konjac glucomannan, carboxymethyl konjac At least one of glucomannan or deacetyl konjac glucomannan.
- 一种含NADH或NADPH的软胶囊的制备方法,其特征在于,包括下述制备步骤:A preparation method of soft capsules containing NADH or NADPH, which is characterized in that it comprises the following preparation steps:将食用植物油或/和可食用醇搅拌加热熔融,冷却后,再将NADH或NADPH与所述食用植物油或/和可食用醇搅拌混合均匀,研磨、过筛后得到原料混合液;Stir and melt the edible vegetable oil or/and edible alcohol, and after cooling, stir and mix NADH or NADPH with the edible vegetable oil or/and edible alcohol evenly, and obtain a raw material mixture after grinding and sieving;将水与胶囊外壳成型原料搅拌混合均匀,抽真空脱气,得到无色胶液; Stir and mix the water and the capsule shell molding materials evenly, vacuum and degas to obtain a colorless glue;用粘度仪检测胶液粘度达到10000mPa.s以上时,将胶液降温;When the viscosity of the glue liquid reaches 10000mPa.s or more by the viscometer, the glue liquid is cooled down;将降温后的胶液过筛;Sieve the cooled glue;将所述原料混合液与过筛后所述的胶液用制胶囊机制备软胶囊,定型、干燥。The raw material mixture and the sieved glue are used to prepare soft capsules with a capsule making machine, which is shaped and dried.
- 如权利要求9所述的含NADH或NADPH的软胶囊的制备方法,其特征在于,在NADH或NADPH与食用植物油或/和可食用醇搅拌混合之前,还包括下述步骤:The method for preparing NADH or NADPH-containing soft capsules according to claim 9, characterized in that, before the NADH or NADPH is mixed with edible vegetable oil or/and edible alcohol, the method further comprises the following steps:将NADH或NADPH先与脂溶性抗酸剂或/和抗氧化剂按配比混合均匀、过筛,得到混合物A,然后再使所述混合物A与加热熔融冷却后的食用植物油或/和可食用醇搅拌混合30-60Min,研磨、过筛后得到原料混合液。Mix NADH or NADPH with fat-soluble antacids or/and antioxidants according to the ratio and mix them evenly and sieving to obtain mixture A, and then stir the mixture A with the edible vegetable oil or/and edible alcohol after heating, melting and cooling Mix for 30-60Min, grind and siev to obtain a raw material mixture.11.如权利要求1-8任一项所述的含NADH或NADPH的软胶囊以及权利要求9或10所述制备方法制备的软胶囊在药物和/或保健品领域的应用。11. Application of the soft capsule containing NADH or NADPH according to any one of claims 1-8 and the soft capsule prepared by the preparation method according to claim 9 or 10 in the field of medicine and/or health care products.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910458329.5 | 2019-05-29 | ||
CN201910458329.5A CN110339179A (en) | 2019-05-29 | 2019-05-29 | Soft capsule and its preparation method and application containing NADH or NADPH |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020238297A1 true WO2020238297A1 (en) | 2020-12-03 |
Family
ID=68174415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2020/076287 WO2020238297A1 (en) | 2019-05-29 | 2020-02-22 | Soft capsule containing nadh or nadph, preparation method therefor and application thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110339179A (en) |
WO (1) | WO2020238297A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110339179A (en) * | 2019-05-29 | 2019-10-18 | 泓博元生命科技(深圳)有限公司 | Soft capsule and its preparation method and application containing NADH or NADPH |
CN113440497B (en) * | 2021-07-20 | 2022-10-11 | 泓博元生命科技(深圳)有限公司 | Microcapsule powder stable in gastric acid and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1713916A (en) * | 2002-11-19 | 2005-12-28 | 奴洛皮亚生态营养医学研究有限公司 | NADH/NADPH-containing compound |
CN109172701A (en) * | 2018-10-12 | 2019-01-11 | 泓博元生命科技(深圳)有限公司 | A kind of composition and preparation method and application containing NADH |
CN109646423A (en) * | 2018-12-03 | 2019-04-19 | 泓博元生命科技(深圳)有限公司 | Boiomacromolecule nanosphere containing NADH and the preparation method and application thereof |
CN110339179A (en) * | 2019-05-29 | 2019-10-18 | 泓博元生命科技(深圳)有限公司 | Soft capsule and its preparation method and application containing NADH or NADPH |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107260702B (en) * | 2017-07-13 | 2020-06-16 | 西南科技大学 | Preparation method of konjac glucomannan-gelatin-based capsule |
WO2019119445A1 (en) * | 2017-12-22 | 2019-06-27 | 邦泰生物工程(深圳)有限公司 | Nadh compound, and formulation and application thereof |
CN108703951B (en) * | 2018-08-27 | 2020-12-01 | 泓博元生命科技(深圳)有限公司 | Modified KGM lecithin NADH-loaded transdermal ethosome, preparation process and application thereof |
CN109172545A (en) * | 2018-10-15 | 2019-01-11 | 泓博元生命科技(深圳)有限公司 | The NADH nanosphere and its preparation process of cladding konjak glucomannan and application |
-
2019
- 2019-05-29 CN CN201910458329.5A patent/CN110339179A/en active Pending
-
2020
- 2020-02-22 WO PCT/CN2020/076287 patent/WO2020238297A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1713916A (en) * | 2002-11-19 | 2005-12-28 | 奴洛皮亚生态营养医学研究有限公司 | NADH/NADPH-containing compound |
CN109172701A (en) * | 2018-10-12 | 2019-01-11 | 泓博元生命科技(深圳)有限公司 | A kind of composition and preparation method and application containing NADH |
CN109646423A (en) * | 2018-12-03 | 2019-04-19 | 泓博元生命科技(深圳)有限公司 | Boiomacromolecule nanosphere containing NADH and the preparation method and application thereof |
CN110339179A (en) * | 2019-05-29 | 2019-10-18 | 泓博元生命科技(深圳)有限公司 | Soft capsule and its preparation method and application containing NADH or NADPH |
Non-Patent Citations (2)
Title |
---|
CAI, NAN ET AL.: "A Review of Research on Non-gelatin Soft Capsule", PHARMACEUTICAL AND CLINICAL RESEARCH, vol. 16, no. 3, 30 June 2008 (2008-06-30), ISSN: 1673-7806, DOI: 20200515163233A * |
DAI, YI: "Non-official translation: Overview and Process of Soft Capsules", SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL, no. 9, 31 December 1995 (1995-12-31), ISSN: 1006-1533, DOI: 20200515154926Y * |
Also Published As
Publication number | Publication date |
---|---|
CN110339179A (en) | 2019-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5140585B2 (en) | Reduced coenzyme Q10-containing composition and method for producing the same | |
CN103282028B (en) | The method of the stable Gelseal of preparation containing microencapsulation probiotic bacteria | |
CN114306272A (en) | Plant soft capsule and preparation method and application thereof | |
TW200836771A (en) | Particulate composition comprising bioactive substance and method of producing the same | |
JP5244790B2 (en) | Reduced coenzyme Q10-containing particulate composition and method for producing the same | |
WO2020238297A1 (en) | Soft capsule containing nadh or nadph, preparation method therefor and application thereof | |
CN101874630A (en) | Brain health-care product for improving memory and cognitive power | |
TW200938214A (en) | Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same | |
CN103536574A (en) | Coenzyme Q10 soft capsule and preparation method thereof | |
CN103251572B (en) | Preparation method of theaflavin enteric microcapsule, as well as product prepared by preparation method and application of product | |
CN103478522A (en) | Donkey-hide gelatin and propolis soft capsules and preparation method thereof | |
KR102483912B1 (en) | Method for producing soft capsule type functional health food | |
CN101288675A (en) | Medicine for curing cardio-cerebralvascular diseases and production method thereof | |
CN110898027A (en) | Vitamin K2 (MK-7) soft capsule for promoting calcium in blood to enter bone and preparation method thereof | |
CN109394724B (en) | Butylphthalide liquid hard capsule preparation and preparation method thereof | |
WO2014134834A1 (en) | Composition and food comprising same and preparation method of food | |
CN107929258A (en) | A kind of plant hollow capsule | |
CN112957409A (en) | Grape seed and safflower seed oil composition and application thereof | |
JP2009149584A (en) | Reduced coenzyme q10-containing particulate composition and its manufacturing method | |
CN114190555B (en) | A dripping pill with antioxidant effect and its preparation method | |
CN111773198A (en) | Novel soft capsule of eldecalcitol and preparation method thereof | |
CN104490802A (en) | Salidroside enteric-coated tablets and preparation method thereof | |
JPWO2020071393A1 (en) | Hard capsules with improved strength and their manufacturing methods | |
CN109793780A (en) | It is a kind of for the hypoglycemic substance of type II diabetes, preparation method and applications | |
CN117224429B (en) | Nicotinamide/peptide solid-liquid separation skin care composition containing hydroxyethyl cellulose as disintegrating agent and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20813214 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20813214 Country of ref document: EP Kind code of ref document: A1 |